Retail sale of pharmaceutical products
ARCO INTERPHARMA AS
Revenue 2025
NOK 739,000
Operating profit
NOK 134,000
Equity
NOK 1.6m
Incorporated
1977
Share capital
NOK 100,000
Key figures · 2025
Current ratio
22.32
Equity ratio
96.0%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 18.2% | |
| Net margin (%%) | 19.1% | |
| Return on assets (%%) | 8.0% | |
| Likviditet | ||
| Current ratio | 22.32 | |
| Working capital | 1.4m | |
| Soliditet | ||
| Equity ratio (%%) | 96.0% | |
| Debt-to-equity ratio | 0.04 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.